About the Equity Working Group

In the field of outcome research, instruments (tools used to measure outcomes) are a potential source of health inequity. This is because they are often developed and tested in populations who regularly take part in research i.e. predominantly white, middle class and well-educated. As a result, they may not measure the outcome as well when applied to under-represented populations.

The aim of this working group is to describe the key questions for researchers to consider to promote health equity when developing or using outcome measures in rheumatology. We will discuss the key ways that population differences can be considered when developing or selecting an instrument for a study.

Jennifer Barton

Jennifer Barton

Co-Chair

Peter Brooks

Peter Brooks

Co-Chair

Francis Guillemin

Francis Guillemin

Co-Chair

Jennifer Petkovic

Jennifer Petkovic

Co-Chair

Peter Tugwell

Peter Tugwell

Co-Chair

Aimee Wattiaux

Fellow

Willemina Campbell

Willemina Campbell

Patient Research Partner

Regina Greer-Smith

Regina Greer-Smith

Patient Research Partner

cathis hofstetter

Catherine Hofstetter

Patient Research Partner

Equity Working Group Overview

OMERACT 2020 Virtual Equity Special Interest Group

Working Group Publications

Working Group Members:

Cheryl Barnabe
Christie Bartels
Jennifer Barton
Dorcas Beaton
Annelies Boonen
Peter Brooks
Rachelle Buchbinder
Willemina Campbell
Robin Christensen
Maarten de Wit
Jonathan Epstein
Niti Goel
Allyson Jones

Charles Goldsmith
Regina Greer Smith
Glen Hazelwood
Catherine Hofstetter
Jenny Humphreys
Janet Jull
Diane Lacaille
Alex Lee
Anne Lyddiatt
Lara Maxwell
Sabrina Mai Neilsen
Jordi Pardo Pardo
Adewale O Adebajo

Jennifer Petkovic
Christoph Pohl
Tamara Rader
Nancy Santesso
Bev Shea
Jasvinder Singh
Antoine Sreih
Karine Toupin-April
Peter Tugwell
Valerie Umaefulam
Aimée Wattiaux
Vivian Welch
Grayson Schultz

Scroll to Top